Ken Johnson is the SVP of Clinical Development, Regulatory, Quality Assurance & Medical Affairs at Xeris Pharmaceuticals. Ken has over 15 years of experience in the pharmaceutical industry, including executive positions at major companies such as Merck, Circassia, Durata Therapeutics, Horizon Pharma, and Takeda Pharmaceuticals. Ken is a highly respected figure in the medical community, and their work has helped to improve the lives of countless patients around the world.
Ken Johnson earned their PharmD from the University of Minnesota. Ken then went on to complete a pharmacy residency at the University of Minnesota.
Ken Johnson works with Beth P. Hecht - General Counsel & Secretary, Allison Wey - SVP, Investor Relations & Corporate Communications, and Steve Pieper - CFO. Their manager is Paul Edick, Chairman & CEO .
Current role